000 | 01612 a2200457 4500 | ||
---|---|---|---|
005 | 20250513175331.0 | ||
264 | 0 | _c19990520 | |
008 | 199905s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHigashi, S | |
245 | 0 | 0 |
_aSize of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cMay 1999 |
||
300 |
_a816-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
650 | 0 | 4 | _aEmulsions |
650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHepatic Artery |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xblood |
650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aSolutions |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aWater |
650 | 0 | 4 |
_aalpha-Fetoproteins _xmetabolism |
700 | 1 | _aTabata, N | |
700 | 1 | _aKondo, K H | |
700 | 1 | _aMaeda, Y | |
700 | 1 | _aShimizu, M | |
700 | 1 | _aNakashima, T | |
700 | 1 | _aSetoguchi, T | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 289 _gno. 2 _gp. 816-9 |
|
999 |
_c10174861 _d10174861 |